Description
Thymosin Alpha-1 (TA1) 10 mg — Immune-Modulating Peptide for Host-Defense Research
Thymosin Alpha-1 (TA1) is a 28–amino-acid peptide originally isolated from
thymic extracts and later produced synthetically as a defined research molecule. In preclinical
and clinical research, TA1 has been investigated for its effects on T-cell function,
innate immunity, and host-defense pathways in a variety of infectious, oncologic,
and immunologic models.
What It Is
- Class: Thymic-derived immunomodulatory peptide analog
- Length: 28 amino acids
- Research focus: T-lymphocyte maturation/activation, innate immune signals,
and host-response modulation under infectious or stress conditions.
Proposed Mechanisms (Preclinical)
T-Cell & Adaptive Immunity
- Explored for enhancement of T-cell differentiation and activation,
including CD4+ and CD8+ subsets. - Investigated for effects on Th1/Th2 balance and cytokine profiles
in immune-challenge models. - Model-dependent modulation of regulatory T-cell and effector
populations.
Innate Immunity & Host Defense
- Studied for upregulation of innate immune receptors and
pathogen-recognition pathways in preclinical systems. - Evaluated for changes in NK-cell activity, dendritic-cell function,
and phagocytic responses. - Interest in synergy with vaccination or antimicrobial strategies
in selected models.
Selected Research Highlights
- Infectious Disease Models: TA1 has been studied as an immunomodulatory
adjunct in viral and other infectious settings, focusing on host-response markers,
viral-load dynamics, and clinical endpoints in select trials. - Oncology & Immunotherapy: Experimental and early clinical work has
examined TA1 combined with chemotherapy, immunotherapy, or vaccination strategies for
potential effects on immune parameters and outcomes. - Immune Dysregulation: Research includes evaluation in states of
immune suppression or dysregulation, tracking changes in lymphocyte
subsets, cytokines, and global immune competence markers.
Chemical & Handling Information
- Type: Synthetic thymic peptide analog
- Peptide length: 28 amino acids
- Appearance: White to off-white lyophilized powder
Specifications
- Peptide: Thymosin Alpha-1 (TA1)
- Amount: 10 mg per vial
- Form: Lyophilized powder
- Purity: ?99% (HPLC); COA per lot available
- Packaging: Sealed vials suitable for standard laboratory handling
Storage & Stability
- Store lyophilized vials in a cool, dry place, protected from light.
- Refrigeration or freezing of the lyophilized peptide is recommended for extended stability,
according to laboratory SOPs. - After reconstitution, store at 2–8 °C for short-term use.
- For long-term storage, aliquot and freeze at ?20 °C or below; avoid repeated freeze–thaw cycles.
Scott Steele –
As described, couldn’t be any happier. Great overall 10/10